Effect of 21-aminosteroid pretreatment in compression trauma to the spinal cord. 1994

S S Haghighi, and A Pérez-Espejo, and X Z Geng, and J Padratzik, and J J Oro, and L Spollen
Division of Neurosurgery, University of Missouri-Columbia.

The present work was performed to establish whether pre-injury administration of the 21-Aminosteroid, U-74389F, is beneficial for treatment of acute spinal cord trauma in rats, as it has been demonstrated that the bolus administration of the same compound one hour after injury facilitates the return of the spinal cord function as measured by electrophysiological recordings in this compression animal model of spinal cord trauma. Cortical somatosensory evoked potentials (CSSEPs) were recorded as an indicator of spinal cord function before and after a severe compression injury. Vital signs and the CSSEPs were monitored up to five hours post-injury. U-4389F treatment was given as a single injection (15 mg kg-1) one hour prior to the injury which was followed by a continuous infusion (3 mg kg-1h-1) during the procedure. The CSSEPs were abolished immediately after this injury both, in the untreated and treated animal groups. The majority of the treated animals (80%) demonstrated recovery of the CSSEPs within the second hour post-injury. The control group showed 40% recovery at this time period. At five hours post-injury, recovery rates were 47% and 87% for control and treated groups respectively. We conclude that the administration of the 21-Aminosteroid, U74389F, one hour prior to spinal cord injury facilitates the return of spinal cord function as measured by CSSEPs in a compression rat model of acute spinal cord trauma, supporting and verifying our previous experiences using the same compound as i.v. bolus injections one, two and three hours after the trauma, respectively.

UI MeSH Term Description Entries
D008297 Male Males
D011281 Pregnatrienes Pregnane derivatives containing three double bonds in the ring structures.
D011292 Premedication Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics (ANTIBIOTIC PROPHYLAXIS) and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION. Premedications
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D005073 Evoked Potentials, Somatosensory The electric response evoked in the CEREBRAL CORTEX by stimulation along AFFERENT PATHWAYS from PERIPHERAL NERVES to CEREBRUM. Somatosensory Evoked Potentials,Evoked Potential, Somatosensory,Somatosensory Evoked Potential
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous

Related Publications

S S Haghighi, and A Pérez-Espejo, and X Z Geng, and J Padratzik, and J J Oro, and L Spollen
January 1994, Acta neurologica Scandinavica,
S S Haghighi, and A Pérez-Espejo, and X Z Geng, and J Padratzik, and J J Oro, and L Spollen
January 1997, Experimental brain research,
S S Haghighi, and A Pérez-Espejo, and X Z Geng, and J Padratzik, and J J Oro, and L Spollen
August 1981, Journal of neurosurgery,
S S Haghighi, and A Pérez-Espejo, and X Z Geng, and J Padratzik, and J J Oro, and L Spollen
January 1991, Journal of neurotrauma,
S S Haghighi, and A Pérez-Espejo, and X Z Geng, and J Padratzik, and J J Oro, and L Spollen
October 1993, Neurological research,
S S Haghighi, and A Pérez-Espejo, and X Z Geng, and J Padratzik, and J J Oro, and L Spollen
January 1995, Veterinary surgery : VS,
S S Haghighi, and A Pérez-Espejo, and X Z Geng, and J Padratzik, and J J Oro, and L Spollen
March 1988, Journal of neurosurgery,
S S Haghighi, and A Pérez-Espejo, and X Z Geng, and J Padratzik, and J J Oro, and L Spollen
September 1980, Journal of neurosurgery,
S S Haghighi, and A Pérez-Espejo, and X Z Geng, and J Padratzik, and J J Oro, and L Spollen
June 1990, The Journal of surgical research,
S S Haghighi, and A Pérez-Espejo, and X Z Geng, and J Padratzik, and J J Oro, and L Spollen
February 1999, Journal of neurotrauma,
Copied contents to your clipboard!